Mesoblast Limited MESO
$ 14.44
-13.87%
Annual report 2022
added 08-31-2022
Country |
Australia |
IPO year |
2015 |
Industry |
Biotechnology |
Stock Exchange |
NASDAQ GLOBAL |
CEO |
Dr. Silviu Itescu |
Employees in the company |
102 |
Shares |
649 M |
Market Cap[1] |
$ 9.37 B |
EBITDA (LTM) |
- |
P/E (LTM) |
-0.5 |
P/S (LTM) |
57.32 |
EPS (LTM) |
-7.57 |
Other stocks of industry "Biotechnology"
References
- Pavone, P. (2019). Market capitalization and financial variables: Evidence from Italian listed companies. International Journal of Academic Research Business and Social Sciences, 9(3), 1356-1371.